For decades, seasonal influenza vaccines were produced primarily in embryonated eggs. Live attenuated influenza vaccine (LAIV), administered intranasally, became available in 2003. Over the past decade, additional...
The pneumococcus: A condensed overview Streptococcus pneumoniae is a Gram-positive diplococcus whose polysaccharide capsule — detectable via the Quellung reaction — is both its main virulence factor and the target of...
Shigella vaccine breakthrough The live-attenuated oral Shigella sonnei vaccine WRSs2 reported 89% efficacy against shigellosis in a phase 2 controlled human infection trial — the highest protection rate ever recorded...
Asia (Southeast Asia, China, India) India — UIP performance and adult immunization push Routine childhood coverage in India remains high, with ≥96% of children 12–23 months having received at least one vaccine; notable...
Western vaccine manufacturers Pfizer-BioNTech: Expanded RSV vaccine recommendations for older adults The Centers for Disease Control and Prevention (CDC) updated its guidance to recommend the Pfizer-BioNTech RSV vaccine...
Despite over five decades of the availability of safe and efficacious vaccines, the global failure to eliminate measles is not a consequence of scientific uncertainty, vaccine inefficacy, or insurmountable logistical...